Current Search Criteria: Intervention: Isoniazid, Rifampicin, Pyrazinamide, Ethambutol (HRZE)
Found 26 matching trials
PK Study of Anti-TB Drugs PHASE1 This is a prospective descriptive and pharmacokinetic study will be conduct...
Show More Location
Shoklo Malaria Research Unit
Learn More & Join Trial
Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients N/A The 4-month daily regimen containing moxifloxacin (2HRZEM 7 / 2HRM7) of ICM...
Show More Location
National Institute for Research in Tuberculosis
Learn More & Join Trial
Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis PHASE2 A Phase 2, Single-Centre, Open-Label, Parallel Control Arm, Randomised Clin...
Show More Location
TASK Clinical Research Centre
Learn More & Join Trial
Study of Combinations of Novel Promising Drugs for Pulmonary Tuberculosis PHASE2 A phase 2, two-part, multicentre, open label, controlled, randomised clinic...
Show More Learn More & Join Trial
HRZE Fasted/Fed in Newly Diagnosed TB PHASE2 WHO recommends to take TB drugs while fasting: if TB drugs are taken with f...
Show More Location
Sardjito Central Hospital
Learn More & Join Trial
A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis. PHASE2 The purpose of this study is to determine the mycobactericidal activity of ...
Show More Location
The Aurum Institute: Tembisa Hospital
Learn More & Join Trial
Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis PHASE2 A Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bacterici...
Show More Location
TASK Clinical Research Centre
Learn More & Join Trial
Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients PHASE2 To evaluate the efficacy, safety and tolerability at 8 weeks (2-months), 52...
Show More Learn More & Join Trial
A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001) PHASE2 The purpose of this study is to evaluate the mycobactericidal activity, saf...
Show More Location
TASK Clinical Research Centre
Learn More & Join Trial
Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis PHASE2 Although effective therapy for tuberculosis is available, TB continues to c...
Show More Location
Centro de Referência Professor Hélio Fraga - ENSP - FIOCRUZ
Learn More & Join Trial